Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Investment

Super funds to reap returns from $2.2bn biotech exit

Brandon Capital, a life sciences venture capital firm has exited from its investment in Myricx Bio, following its agreement to be acquired by Novartis for US$1.5 billion ($2.2bn).

Upgrade your subscription to access this article

And gain access to:
  • All website content, including archived news
  • Home page news customisation
  • Tech Zone, your technical resource library
And more
Already A Subscriber?

Read more: Brandon CapitalMyricx BioNovartis forAware SuperFrancis Crick InstituteHESTAHostplusImperial College LondonMohit RawatQICRoberto SolariStephen Thompson